Cite
HARVARD Citation
shi, y. et al. (n.d.). 576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients. Open forum infectious diseases. pp. S352-S353. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
shi, y. et al. (n.d.). 576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients. Open forum infectious diseases. pp. S352-S353. [Online].